- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 17 x NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- 31 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.18: 5 residues within 4Å:- Chain A: N.123, A.124, T.125, N.126, F.128
Ligand excluded by PLIPNAG.19: 5 residues within 4Å:- Chain A: H.338, F.341, N.342, F.370, W.435
Ligand excluded by PLIPNAG.20: 3 residues within 4Å:- Chain A: N.330, P.578, Q.579
Ligand excluded by PLIPNAG.21: 3 residues within 4Å:- Chain A: N.615, T.617, E.618
Ligand excluded by PLIPNAG.22: 2 residues within 4Å:- Chain A: Y.654, N.656
Ligand excluded by PLIPNAG.23: 3 residues within 4Å:- Chain A: S.707, N.708
- Chain C: Y.795
Ligand excluded by PLIPNAG.24: 4 residues within 4Å:- Chain A: A.705, E.1071, K.1072, N.1073
Ligand excluded by PLIPNAG.25: 3 residues within 4Å:- Chain A: Y.31, N.33, N.64
Ligand excluded by PLIPNAG.26: 1 residues within 4Å:- Chain A: N.165
Ligand excluded by PLIPNAG.27: 1 residues within 4Å:- Chain A: N.233
Ligand excluded by PLIPNAG.28: 6 residues within 4Å:- Chain B: N.123, T.125, N.126, V.127, F.128, V.171
Ligand excluded by PLIPNAG.29: 3 residues within 4Å:- Chain B: Y.31, F.62, N.64
Ligand excluded by PLIPNAG.30: 4 residues within 4Å:- Chain B: S.113, E.133, N.164, N.165
Ligand excluded by PLIPNAG.31: 5 residues within 4Å:- Chain B: N.233, T.235
- Chain C: E.464, R.465, D.466
Ligand excluded by PLIPNAG.32: 2 residues within 4Å:- Chain B: N.330, Q.579
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain B: N.615, T.617
Ligand excluded by PLIPNAG.34: 1 residues within 4Å:- Chain B: N.656
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain A: Y.795
- Chain B: S.707, N.708
Ligand excluded by PLIPNAG.36: 4 residues within 4Å:- Chain B: A.705, E.1071, K.1072, N.1073
Ligand excluded by PLIPNAG.37: 4 residues within 4Å:- Chain B: R.345, A.347, N.353, T.355
Ligand excluded by PLIPNAG.38: 4 residues within 4Å:- Chain B: H.338, F.341, N.342, F.370
Ligand excluded by PLIPNAG.39: 6 residues within 4Å:- Chain C: N.123, A.124, T.125, N.126, V.127, V.171
Ligand excluded by PLIPNAG.40: 3 residues within 4Å:- Chain C: Y.31, F.62, N.64
Ligand excluded by PLIPNAG.41: 2 residues within 4Å:- Chain C: N.164, N.165
Ligand excluded by PLIPNAG.42: 5 residues within 4Å:- Chain A: K.461, E.464
- Chain C: T.109, N.233, T.235
Ligand excluded by PLIPNAG.43: 3 residues within 4Å:- Chain C: N.615, T.617, E.618
Ligand excluded by PLIPNAG.44: 2 residues within 4Å:- Chain C: Y.654, N.656
Ligand excluded by PLIPNAG.45: 4 residues within 4Å:- Chain B: I.793, Y.795
- Chain C: S.707, N.708
Ligand excluded by PLIPNAG.46: 4 residues within 4Å:- Chain C: A.705, E.1071, K.1072, N.1073
Ligand excluded by PLIPNAG.47: 2 residues within 4Å:- Chain C: N.342, T.344
Ligand excluded by PLIPNAG.48: 1 residues within 4Å:- Chain C: N.330
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Liu, P. et al., Spike N354 glycosylation augments SARS-CoV-2 fitness for human adaptation through structural plasticity. Natl Sci Rev (2024)
- Release Date
- 2024-06-26
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 17 x NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- 31 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Liu, P. et al., Spike N354 glycosylation augments SARS-CoV-2 fitness for human adaptation through structural plasticity. Natl Sci Rev (2024)
- Release Date
- 2024-06-26
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C